Caricamento quotazioni...
Previsioni
| Acquista |
1 |
| Mantieni |
0 |
| Vendi |
0 |
Notizie Vai al feed delle notizie
Inspira Technologies wins $596,000 order for AME system from Irish research university
Inspira Technologies has secured a $596,000 order for an AME system (additive manufacturing of electronics) from an Irish technological research university. The company received a non‑refundable 40% advance payment, with the remainder due on delivery. The order includes recurring revenue from consumables, wear parts and annual service fees; delivery, installation and training are planned in the coming weeks and are intended to serve as a reference for further academic and commercial collaborations in Europe. Inspira has a market capitalization of $19.28 million and annual revenue of $290,000. » Altro su de.investing.com
Inspira Technologies enters quantum computing and plans to rebrand as QTREX
Inspira Technologies announces a strategic entry into the quantum computing sector and aims to use its additively manufactured AME platform to address 3D connectivity issues in dilution cryostats to improve qubit coherence and system stability. The company, led by CEO Dagi Ben-Noon and COO Avi Shabtay, reports a proof of concept for integrating qubit-relevant components and is negotiating partnerships but provides no details or timelines. Inspira plans to continue its medical technology division as a subsidiary, intends to change its name to QTREX, and points to large market forecasts, but remains financially unprofitable and shows high cash outflows. » Altro su de.investing.com
Inspira Technologies terminates two financing agreements
Inspira Technologies announces the written termination of its sales agreement with A.G.P./Alliance Global Partners dated 17 February 2026 and its standby equity purchase agreement with YA II PN, Ltd. dated 12 December 2025. The company has no outstanding obligations under either agreement and no further payments will be made. Inspira cites the goal of a disciplined capital structure as the reason for the move while it prepares for the next strategic phase; the stock has recently fallen sharply and, according to InvestingPro, is fairly valued. » Altro su de.investing.com
Dati finanziari dell'azienda
| (EUR) | giugno 2025 | YoY |
|---|---|---|
| Ricavi | 122,6K | - |
| Utile lordo | 848,42 | - |
| Utile netto | -2,71 Mln | - |
| EBITDA | -3,04 Mln | - |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 22,55 Mln € |
Numero di azioni | 24,08 Mln |
Massimo/minimo a 52 settimane | 1,87 € - 0,30 € |
| Dividendi | No |
Beta | 2,33 |
Rapporto P/E | - |
Rapporto PEG | - |
Rapporto P/B | - |
Rapporto P/S | - |
Profilo aziendale
Inspira Technologies Oxy B.H.N. Ltd., un'azienda specializzata in dispositivi medici, si occupa di ricerca, sviluppo, produzione e commercializzazione di tecnologie per il supporto respiratorio, con l'obiettivo di offrire un'alternativa alla ventilazione meccanica invasiva (MV) per il trattamento dell'insufficienza respiratoria. Il suo prodotto principale è il sistema di tecnologia di respirazione aumentata (ART), un sistema di supporto respiratorio composto da una cannula a doppio lume portatile e mininvasiva, inserita nella vena giugulare, che utilizza l'ossigenazione diretta del sangue extracorporea per innalzare e stabilizzare i livelli di saturazione dell'ossigeno in calo. L'azienda era precedentemente nota come Insense Medical Ltd. e ha cambiato denominazione in Inspira Technologies Oxy B.H.N. Ltd. nel luglio 2020. La società è stata costituita nel 2018 e ha sede a Ra'annana, in Israele.
| Nome | INSPIRA TECH OXY IS-,125 Aktie |
| CEO | Dagi Shahar Ben-Noon |
| Sede centrale | Ra'anana,
Israele |
| Sito web | |
| Settore | Beni voluttuari |
| Industria | Beni durevoli per la casa |
| Quotazione in borsa | 14/07/2021 |
| Dipendenti | 39 |
Simboli di borsa
| Borsa | Simbolo |
|---|---|
NASDAQ | IINN |